A new study published in the journal Politics and the Life Sciences sheds light on the psychological roots of conspiracy ...
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...
UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...
Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to ...
The newly established CAB has been formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The CAB ...
India Today on MSN
Gen Z has more comfort than any generation. So why the anxiety?
Gen Z is experiencing unprecedented levels of anxiety driven by digital and environmental stressors. This rise highlights the ...
Patrick Clancy claims his wife's doctors "knew or should have known that she presented a real, clear, and present danger of ...
This guidance is for integrated care boards (ICBs) and providers of eating disorder services and sets out how to design collaborative, integrated services that support all children, young people, and ...
San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...
Aligned with U.S. Food and Drug Administration (FDA) on Registrational Path for RE104 in Postpartum Depression (PPD); On Track to Initiate Phase 3 Trial in 2026 -- ...
RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...
After a clampdown on a popular psychoactive drug, doctors say many young people have switched to abusing a cheaper, addictive alternative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback